CTNM · NASDAQ · Biotechnology

Contineum Therapeutics (CTNM)

Discovers and develops oral small-molecule therapies for neuroscience, inflammation and immunology.

$12.75
vs last close−0.65 (−4.85%)
  1. Contineum (CTNM) Q2 R&D Jumps 78%

    The Motley Fool